Selected research
Industry Growth & Trends
Global Swine Epidemic Diarrhea Vaccines Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Swine Epidemic Diarrhea Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Swine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Swine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Swine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Swine Epidemic Diarrhea Vaccines market include CAVAC, Qilu Animal Health, Zoetis, Nisseiken, Komipharm, Harrisvaccines, Inc. and Green Cross Veterinary Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Swine Epidemic Diarrhea Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Swine Epidemic Diarrhea Vaccines market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Swine Epidemic Diarrhea Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Swine Epidemic Diarrhea Vaccines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Swine Epidemic Diarrhea Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Swine Epidemic Diarrhea Vaccines Market by Company
CAVAC
Qilu Animal Health
Zoetis
Nisseiken
Komipharm
Harrisvaccines, Inc.
Green Cross Veterinary Products
Swine Epidemic Diarrhea Vaccines Segment by Type
Live Vaccines
Killed Vaccines
Swine Epidemic Diarrhea Vaccines Segment by Application
Piglets
Adults Pigs
Swine Epidemic Diarrhea Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Epidemic Diarrhea Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Epidemic Diarrhea Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Epidemic Diarrhea Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Swine Epidemic Diarrhea Vaccines companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Live Vaccines
- Killed Vaccines
Applications
- Piglets
- Adults Pigs
Companies covered
- CAVAC
- Qilu Animal Health
- Zoetis
- Nisseiken
- Komipharm
- Harrisvaccines, Inc.
- Green Cross Veterinary Products
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Swine Epidemic Diarrhea Vaccines Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2021-2032)
- 1.4.1 Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2021-2026)
- 1.4.2 Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2027-2032)
- 1.5 Key Regions Swine Epidemic Diarrhea Vaccines Market Size (2021-2032)
- 1.5.1 North America Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (2021-2032)
- 1.5.4 South America Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (2021-2032)
2 Swine Epidemic Diarrhea Vaccines Market by Type
- 2.1 Type Introduction
- 2.1.1 Live Vaccines
- 2.1.2 Killed Vaccines
- 2.2 Global Swine Epidemic Diarrhea Vaccines Market Size by Type
- 2.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size Overview by Type (2021-2032)
- 2.2.2 Global Swine Epidemic Diarrhea Vaccines Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Swine Epidemic Diarrhea Vaccines Market Size Forecasted by Type (2027-2032)
- 2.3 Global Swine Epidemic Diarrhea Vaccines Market Size by Regions
- 2.3.1 North America Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Type (2021-2026)
3 Swine Epidemic Diarrhea Vaccines Market by Application
- 3.1 Type Introduction
- 3.1.1 Piglets
- 3.1.2 Adults Pigs
- 3.2 Global Swine Epidemic Diarrhea Vaccines Market Size by Application
- 3.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size Overview by Application (2021-2032)
- 3.2.2 Global Swine Epidemic Diarrhea Vaccines Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Swine Epidemic Diarrhea Vaccines Market Size Forecasted by Application (2027-2032)
- 3.3 Global Swine Epidemic Diarrhea Vaccines Market Size by Regions
- 3.3.1 North America Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Swine Epidemic Diarrhea Vaccines Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Swine Epidemic Diarrhea Vaccines Industry Trends
- 4.2 Swine Epidemic Diarrhea Vaccines Industry Drivers
- 4.3 Swine Epidemic Diarrhea Vaccines Industry Opportunities and Challenges
- 4.4 Swine Epidemic Diarrhea Vaccines Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Swine Epidemic Diarrhea Vaccines Revenue (2021-2026)
- 5.2 Global Swine Epidemic Diarrhea Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Swine Epidemic Diarrhea Vaccines Key Company Headquarters & Area Served
- 5.4 Global Swine Epidemic Diarrhea Vaccines Company, Product Type & Application
- 5.5 Global Swine Epidemic Diarrhea Vaccines Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Swine Epidemic Diarrhea Vaccines Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Swine Epidemic Diarrhea Vaccines Players Market Share by Revenue in 2025
- 5.6.3 2025 Swine Epidemic Diarrhea Vaccines Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 CAVAC
- 6.1.1 CAVAC Company Information
- 6.1.2 CAVAC Business Overview
- 6.1.3 CAVAC Swine Epidemic Diarrhea Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 CAVAC Swine Epidemic Diarrhea Vaccines Product Portfolio
- 6.1.5 CAVAC Recent Developments
- 6.2 Qilu Animal Health
- 6.2.1 Qilu Animal Health Company Information
- 6.2.2 Qilu Animal Health Business Overview
- 6.2.3 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Product Portfolio
- 6.2.5 Qilu Animal Health Recent Developments
- 6.3 Zoetis
- 6.3.1 Zoetis Company Information
- 6.3.2 Zoetis Business Overview
- 6.3.3 Zoetis Swine Epidemic Diarrhea Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Zoetis Swine Epidemic Diarrhea Vaccines Product Portfolio
- 6.3.5 Zoetis Recent Developments
- 6.4 Nisseiken
- 6.4.1 Nisseiken Company Information
- 6.4.2 Nisseiken Business Overview
- 6.4.3 Nisseiken Swine Epidemic Diarrhea Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Nisseiken Swine Epidemic Diarrhea Vaccines Product Portfolio
- 6.4.5 Nisseiken Recent Developments
- 6.5 Komipharm
- 6.5.1 Komipharm Company Information
- 6.5.2 Komipharm Business Overview
- 6.5.3 Komipharm Swine Epidemic Diarrhea Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Komipharm Swine Epidemic Diarrhea Vaccines Product Portfolio
- 6.5.5 Komipharm Recent Developments
- 6.6 Harrisvaccines, Inc.
- 6.6.1 Harrisvaccines, Inc. Company Information
- 6.6.2 Harrisvaccines, Inc. Business Overview
- 6.6.3 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Product Portfolio
- 6.6.5 Harrisvaccines, Inc. Recent Developments
- 6.7 Green Cross Veterinary Products
- 6.7.1 Green Cross Veterinary Products Company Information
- 6.7.2 Green Cross Veterinary Products Business Overview
- 6.7.3 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Product Portfolio
- 6.7.5 Green Cross Veterinary Products Recent Developments
7 North America
- 7.1 North America Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 7.3 North America Swine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 8.3 Europe Swine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 10.3 South America Swine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst